What is the quantitative effect of TZP + LEKT versus TZP + LCD on hepatic fat content as measured by the controlled attenuation parameter (CAP)?
Label:chem
Topic
CAP (in dB/m) is a non-invasive, chemistry-based surrogate of hepatic steatosis derived from FibroScan®.
Answer
CAP decreased by 12.5 % (from 295 ± 16 to 258 ± 10 dB/m) in the TZP + LEKT group versus only 6.7 % (298 ± 17 to 278 ± 12 dB/m) in the TZP + LCD group (p = 0.01 between groups).
Return to Home
Chemical List
Knowledge you may be interested in